Non-Covid revenue for Thyrocare remains stable as margin take a hit in Q2 due to ESOP cost | Thyrocare Technologies Q2 FY23 Result & Earning Call Highlights
Non-Covid revenue for Thyrocare remains stable as margin take a hit in Q2 due to ESOP cost | Thyrocare Technologies Q2 FY23 Result & Earning Call Highlights
Non-Covid revenue for Thyrocare remains stable as margin take a hit in Q2 due to ESOP cost | Thyrocare Technologies Q2 FY23 Result & Earning Call Highlights
Published on 14 November 2022 .Views 17.Comments 0
Download
